Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor A (VEGF-A) have been shown to contribute to cancer cell survival and have been identified as potential therapeutic targets for advanced OC (21, 22). The gene discussed is VEGFA; the disease is cancer.